- Teresa C Frohman, PA-C
Teresa C Frohman, PA-C
- MS Clinical Specialist
- UTSW Medical Center
- Elliot M Frohman, MD, PhD
Elliot M Frohman, MD, PhD
- Professor of Neurology
- University of Texas Southwestern Medical Center
Internuclear ophthalmoparesis (INO), also commonly referred to as intranuclear ophthalmoplegia, is a specific gaze abnormality characterized by impaired horizontal eye movements with weak adduction of the affected eye, and abduction nystagmus of the contralateral eye. It is one of the most localizing brainstem syndromes, resulting from a lesion in the medial longitudinal fasciculus (MLF) in the dorsomedial brainstem tegmentum of either the pons or the midbrain .
Foveation or visual targeting with binocular fusion and stereoscopy (depth perception) requires highly synchronous eye movements that place objects of visual interest on the corresponding points of both retinas. This process is dependent upon the precise coordination between cranial nerves III, IV, and VI, and their interneuronal pathways that project through the medial longitudinal fasciculus (MLF) (figure 1).
The paramedian pontine reticular formation (PPRF) is often referred to as the conjugate gaze center for horizontal eye movements. During horizontal eye movement, the PPRF burst cells innervate the abducens nucleus, which contains two distinctive sets of neurons. Axons from the abducens motorneurons directly innervate the ipsilateral lateral rectus muscle. Axons of the abducens interneurons cross the midline to become the MLF and subsequently innervate the medial rectus subnucleus of the oculomotor complex (cranial nerve nucleus III). This motorneuron innervates the medial rectus muscle.
The MLF exists as a pair of white matter fiber tracts that lie near the midline just under (or ventral to) the fourth ventricle and cerebral aqueduct and extend through the dorsomedial pontine and midbrain tegmentum. Because of their close physical proximity, bilateral injury is common.
An internuclear ophthalmoparesis (INO) results from injury to the MLF within the dorsomedial pontine or midbrain tegmentum. The side of the INO is named by the side of the adduction deficit, which is ipsilateral to the medial longitudinal fasciculus (MLF) lesion [2,3].
- Frohman EM, Zhang H, Kramer PD, et al. MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis. Neurology 2001; 57:762.
- Sakaie K, Takahashi M, Dimitrov I, et al. Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges. Ann N Y Acad Sci 2011; 1233:307.
- Sakaie K, Takahashi M, Sagiyama K, et al. Injury to a specific neural pathway detected by ultra-high-field MRI. Neurology 2014; 82:182.
- Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004; 62:1491.
- Mills DA, Frohman TC, Davis SL, et al. Break in binocular fusion during head turning in MS patients with INO. Neurology 2008; 71:458.
- Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4:111.
- Zee DS, Hain TC, Carl JR. Abduction nystagmus in internuclear ophthalmoplegia. Ann Neurol 1987; 21:383.
- Baloh RW, Yee RD, Honrubia V. Internuclear ophthalmoplegia. I. Saccades and dissociated nystagmus. Arch Neurol 1978; 35:484.
- Flipse JP, Straathof CS, Van der Steen J, et al. Binocular saccadic eye movements in multiple sclerosis. J Neurol Sci 1997; 148:53.
- Zee DS. Internuclear ophthalmoplegia: pathophysiology and diagnosis. Baillieres Clin Neurol 1992; 1:455.
- Bronstein AM, Rudge P, Gresty MA, et al. Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry 1990; 53:200.
- Evinger LC, Fuchs AF, Baker R. Bilateral lesions of the medial longitudinal fasciculus in monkeys: effects on the horizontal and vertical components of voluntary and vestibular induced eye movements. Exp Brain Res 1977; 28:1.
- Ranalli PJ, Sharpe JA. Vertical vestibulo-ocular reflex, smooth pursuit and eye-head tracking dysfunction in internuclear ophthalmoplegia. Brain 1988; 111 ( Pt 6):1299.
- Bolaños I, Lozano D, Cantú C. Internuclear ophthalmoplegia: causes and long-term follow-up in 65 patients. Acta Neurol Scand 2004; 110:161.
- Cremer PD, Migliaccio AA, Halmagyi GM, Curthoys IS. Vestibulo-ocular reflex pathways in internuclear ophthalmoplegia. Ann Neurol 1999; 45:529.
- Zwergal A, Cnyrim C, Arbusow V, et al. Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus. Neurology 2008; 71:590.
- Keane, JR. Internuclear ophthalmoplegia - a reply. Arch Neurol 2006; 63:626.
- Jung DS, Park KP. Posttraumatic bilateral internuclear ophthalmoplegia with exotropia. Arch Neurol 2004; 61:429.
- Keane JR. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients. Arch Neurol 2005; 62:714.
- Müri RM, Meienberg O. The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985; 42:851.
- Meienberg O, Müri R, Rabineau PA. Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis. Arch Neurol 1986; 43:438.
- Frohman EM, Frohman TC, O'Suilleabhain P, et al. Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score. J Neurol Neurosurg Psychiatry 2002; 73:51.
- Frohman TC, Davis SL, Frohman EM. Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Ann N Y Acad Sci 2011; 1233:313.
- Frohman TC, Davis SL, Beh S, et al. Uhthoff's phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol 2013; 9:535.
- Davis SL, Frohman TC, Crandall CG, et al. Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Neurology 2008; 70:1098.
- Eggenberger E, Golnik K, Lee A, et al. Prognosis of ischemic internuclear ophthalmoplegia. Ophthalmology 2002; 109:1676.
- Gray OM, Forbes RB, Morrow JI. Primary isolated brainstem injury producing internuclear ophthalmoplegia. Br J Neurosurg 2001; 15:432.
- Constantoyannis C, Tzortzidis F, Papadakis N. Internuclear ophthalmoplegia following minor head injury: a case report. Br J Neurosurg 1998; 12:377.
- Matsumoto H, Ohminami S, Goto J, Tsuji S. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome. Arch Neurol 2008; 65:827.
- Flint AC, Williams O. Bilateral internuclear ophthalmoplegia in progressive supranuclear palsy with an overriding oculocephalic maneuver. Mov Disord 2005; 20:1069.
- al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994; 89:157.
- Davis TL, Lavin PJ. Pseudo one-and-a-half syndrome with ocular myasthenia. Neurology 1989; 39:1553.
- Korkmaz A, Topaloglu H, Kansu T. Wall eyed bilateral internuclear ophthalmoplegia in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2002; 9:691.
- Lifshitz M, Gavrilov V, Sofer S. Signs and symptoms of carbamazepine overdose in young children. Pediatr Emerg Care 2000; 16:26.
- Solingen LD, Baloh RW, Myers L, Ellison G. Subclinical eye movement disorders in patients with multiple sclerosis. Neurology 1977; 27:614.
- Frohman TC, Frohman EM, O'Suilleabhain P, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology 2003; 61:848.
- SMITH JL, DAVID NJ. INTERNUCLEAR OPHTHALMOPLEGIA. TWO NEW CLINICAL SIGNS. Neurology 1964; 14:307.
- Atlas SW, Grossman RI, Savino PJ, et al. Internuclear ophthalmoplegia: MR-anatomic correlation. AJNR Am J Neuroradiol 1987; 8:243.
- OCULOMOTOR CIRCUITRY
- CLINICAL FEATURES
- Adduction weakness
- Normal convergence
- Abduction nystagmus
- Abduction slowing
- Abnormal vertical eye movements
- Associated syndromes
- - One-and-a-half syndrome
- - Wall-eyed bilateral INO
- Multiple sclerosis
- Cerebrovascular disease
- DIFFERENTIAL DIAGNOSIS
- EVALUATION AND DIAGNOSIS
- Magnetic resonance imaging
- PROGNOSIS AND TREATMENT
- SUMMARY AND RECOMMENDATIONS